Researchers have made a new discovery in the fight against malaria. The study, recently published in Science, identified a new class of antibodies targeting a previously unexplored malaria parasite region.
In a study of nearly 60,000 people by University College London, scientists found people with depression and anxiety before COVID were a "hidden group" - extra vulnerable to long-term health and financial consequences.
The University of York examined psychological states during the UK lockdown, revealing that external surroundings shape "maladaptive thought processes" - with fewer people able to think about the future when isolated.
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explains how glycoscience offers opportunities galore in healthcare.
Mike Smith, Director Large Enterprise & Public Sector at Virgin Media 02 Business, focuses our thoughts on achieving interoperability and driving the digital rebound in healthcare.
In a study spanning fifty years, researchers reveal that transgender people still face a disproportionate likelihood of death - a likelihood not connected to gender-affirming hormone treatment.
Professor Andrew Boulton, President & Professor Akhtar Hussain, President-Elect of the International Diabetes Federation, argue that while there has been a century of saving lives, more must be done to tackle diabetes.
Dee Mathieson, Managing Director at Elekta Ltd, believes that NHS budgets need to directly address the cancer backlog - which remains the second largest cause of death, globally.
Research by the American Osteopathic Association finds that 80% of US medical schools are not investigating LGBTQ health inequalities - as they are not collecting the necessary data.
A study by Yale University, published in JAMA Psychiatry, says that suicidal thoughts in veterans remained stable throughout the isolation of the pandemic.
The research, presented at the European Society of Cardiology Congress 2021, found that teen drinking and smoking has a direct impact on vascular health - with arteries becoming stiffer in those with "heavier usage".
The US Food and Drug Administration (FDA) have approved a third Pfizer dose for people who are immunocompromised - despite the WHO asking countries to wait until 20% were double-vaccinated, globally.
Sir Andrew Pollard, head of the Oxford Vaccine Group, said on Tuesday (10 August) that herd immunity is "mythical" in relation to the Delta variant - as it still infects vaccinated individuals.
